Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathways in cancer | R-HSA-9824443 | map05200 | orphenadrine | 4601 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | orphenadrine | 4601 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | orphenadrine | 4601 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | orphenadrine | 4601 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | orphenadrine | 4601 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | orphenadrine | 4601 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | orphenadrine | 4601 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | orphenadrine | 4601 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | orphenadrine | 4601 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | orphenadrine | 4601 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | orphenadrine | 4601 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | phenelzine | 3675 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | phenelzine | 3675 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | phenelzine | 3675 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | phenelzine | 3675 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | phenelzine | 3675 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | phenelzine | 3675 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | phenelzine | 3675 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | phenelzine | 3675 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | ketoprofen | 3825 | drug-path |